Targeting the Angiotensin System in Posttransplant Airway Obliteration
- 1 July 2000
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 162 (1), 310-315
- https://doi.org/10.1164/ajrccm.162.1.9910114
Abstract
The angiotensin system plays a role in the pathogenesis of fibrotic diseases. We used a rat heterotopic tracheal transplant model of bronchiolitis obliterans (BO) to examine the role of angiotensin converting enzyme (ACE) in development of the fibroproliferative lesion of BO. Isograft and allograft tracheal transplants were performed. Allograft rats received either no treatment (control) or captopril (100 mg/kg/d) in their drinking water. The drug treatment given to the recipient rats was begun 5 days before transplantation, on postoperative Day 1, or on postoperative Day 5. The treatment was continued until postoperative Day 21, when tracheal specimens were harvested and subjected to histologic, immunohistologic, and morphometric analyses. We noted heavy staining for ACE in the obliterated portion of the tracheas of allograft control animals. This area was not present in nontransplanted or isograft tracheas. Captopril administration begun 5 d before transplantation and on postoperative Day 1 resulted in a significant attenuation in the percent airway obliteration (45% and 26%, respectively) as compared with that in control allografts (83%; p < 0.05). This study demonstrates the presence of ACE in the fibroproliferative lesion in a rat model of BO, and shows that inhibition of ACE can limit development of airway obliteration.Keywords
This publication has 24 references indexed in Scilit:
- Decreased expression of angiotensin-converting enzyme in the airway epithelium of asthmatic subjects is associated with eosinophil inflammationJournal of Allergy and Clinical Immunology, 1999
- Renin-Angiotensin System, Hypertrophy and Gene Expression in Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1999
- Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compoundsThe Journal of Heart and Lung Transplantation, 1999
- Angiotensin II plays a pathogenic role in immune-mediated renal injury in miceJCI Insight, 1999
- Dual pathway for angiotensin II formation in human internal mammary arteriesBritish Journal of Pharmacology, 1998
- Pouch Tissue and Angiotensin Peptide GenerationJournal of Molecular and Cellular Cardiology, 1998
- Gene Transfer of Transforming Growth Factor-β1 Prolongs Murine Cardiac Allograft Survival by Inhibiting Cell-Mediated ImmunityHuman Gene Therapy, 1996
- Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat HeartJournal of Molecular and Cellular Cardiology, 1996
- Role of Bradykinin in the Cardiac Effects of Angiotensin-Converting Enzyme InhibitorsJournal of Cardiovascular Pharmacology, 1992
- Potential role of dendritic cells in bronchiolitis obliterans in heart-lung transplantationThe Annals of Thoracic Surgery, 1990